Previous Article | Next Article ![]()
Infection and Immunity, October 2000, p. 5998-6004, Vol. 68, No. 10
Laboratoire de Gastroentérologie et
Nutrition1 and INSERM U364, IFR50,
Faculté de Médecine,2
Université de Nice-Sophia Antipolis, 06107 Nice Cedex 2, France
Received 24 February 2000/Returned for modification 30 March
2000/Accepted 6 June 2000
Use of the nonpathogenic yeast Saccharomyces boulardii
in the treatment of infectious diarrhea has attracted growing interest. The present study designed to investigate the effect of this yeast on
enteropathogenic Escherichia coli (EPEC)-associated disease demonstrates that S. boulardii abrogated the alterations
induced by an EPEC strain on transepithelial resistance,
[3H]inulin flux, and ZO-1 distribution in T84 cells.
Moreover, EPEC-mediated apoptosis of epithelial cells was delayed in
the presence of S. boulardii. The yeast did not modify the
number of adherent bacteria but lowered by 50% the number of
intracellular bacteria. Infection by EPEC induced tyrosine
phosphorylation of several proteins in T84 cells, including p46 and p52
SHC isoforms, that was attenuated in the presence of S. boulardii. Similarly, EPEC-induced activation of the ERK1/2
mitogen-activated protein (MAP) kinase pathway was diminished in the
presence of the yeast. Interestingly, inhibition of the ERK1/2 pathway
with the specific inhibitor PD 98059 decreased EPEC internalization,
suggesting that modulation of the ERK1/2 MAP pathway might account for
the lowering of the number of intracellular bacteria observed in the
presence of S. boulardii. Altogether, this study
demonstrated that S. boulardii exerts a protective effect
on epithelial cells after EPEC adhesion by modulating the signaling
pathway induced by bacterial infection.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Saccharomyces boulardii Preserves the
Barrier Function and Modulates the Signal Transduction Pathway Induced
in Enteropathogenic Escherichia coli-Infected T84
Cells
*
Corresponding author. Mailing address: Laboratoire de
Gastroentérologie, Université de Nice-Sophia Antipolis, 28 Avenue de Valombrose, 06107 Nice Cedex 2, France. Phone: (33)
4-93-37-76-95. Fax: (33) 4-93-81-77-10. E-mail:
czerucka{at}unice.fr.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|